Amplification of thymidylate synthetase in metastatic colorectal cancer patients pretreated with 5-fluorouracil-based chemotherapy
- 31 December 2010
- journal article
- Published by Elsevier BV in European Journal of Cancer
- Vol. 46 (18), 3358-3364
- https://doi.org/10.1016/j.ejca.2010.07.011
Abstract
No abstract availableThis publication has 32 references indexed in Scilit:
- Five-Year Data and Prognostic Factor Analysis of Oxaliplatin and Irinotecan Combinations for Advanced Colorectal Cancer: N9741Journal of Clinical Oncology, 2008
- Molecular determinants of efficacy for 5‐FU‐based treatments in advanced colorectal cancer: mRNA expression for 18 chemotherapy‐related genesInternational Journal of Cancer, 2008
- Copy-number analysis of topoisomerase and thymidylate synthase genes in frozen and FFPE DNAs of colorectal cancersPharmacogenomics, 2008
- Predictive value of thymidylate synthase expression in advanced colorectal cancer patients receiving fluoropyrimidine‐based chemotherapy: Evidence from 24 studiesInternational Journal of Cancer, 2008
- Primer3Plus, an enhanced web interface to Primer3Nucleic Acids Research, 2007
- Induction of thymidylate synthase as a 5-fluorouracil resistance mechanismBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2002
- Prognostic Value of Tumoral Thymidylate Synthase and p53 in Metastatic Colorectal Cancer Patients Receiving Fluorouracil-Based Chemotherapy: Phenotypic and Genotypic AnalysesJournal of Clinical Oncology, 2002
- Predictive value of thymidylate synthase expression in resected metastases of colorectal cancerEuropean Journal of Cancer, 2002
- P53 overexpression predicts poor chemosensitivity to high-dose 5-fluorouracil plus leucovorin chemotherapy for stage IV colorectal cancers after palliative bowel resectionInternational Journal of Cancer, 2001
- ERCC1 and Thymidylate Synthase mRNA Levels Predict Survival for Colorectal Cancer Patients Receiving Combination Oxaliplatin and Fluorouracil ChemotherapyJournal of Clinical Oncology, 2001